Tricardia
Natural health product licensed in Canada
- Licence holder
- Phytogenics Inc.
- NPN or DIN-HM
- 80066249
- Status
- Active licence
- Licence date
- 6 January 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 2-aminoéthanesulfonique Source : Taurine | 220 mg | Not calculated |
| Ubiquinol Source : Ubiquinol | 60 mg | Not calculated |
| Crataegus laevigata Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 mg Potency : 2 % Flavonoids as hyperoside | 200 mg | Not calculated |
| Crataegus laevigata Source : Fleur Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 mg Potency : 2 % Flavonoids as hyperoside | 200 mg | Not calculated |
Non-medicinal ingredients
Farine de riz brun, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to maintain and/or support cardiovascular health Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking cardiac glycosides such as digitalis/digoxin, or blood pressure medication. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking blood pressure medication, consult a health care practitioner prior to use. If you are taking blood thinner medication, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80066249
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.